From R&D operations to manufacturing efforts, this infographic examines how the pharma sector is being affected by current global instability due to political turmoil and soaring energy prices.

This infographic reflects on the evolution of the biotech sector since 2016, tracking rising revenues, investment cuts and drugs that are making it to market.

This infographic looks at the mission to make an effective vaccine against any virus in just 100 days and explores the diseases that are re-emerging that could be combatted with an expedited approach.

Track the access landscape in Latin America by examining medicine spending over the last five years and standout examples of ongoing initiatives founded by pharmaceutical companies to improve access in the region.

This infographic examines how the pharmaceutical industry’s R&D pipeline is evolving, looking at the companies leading the way and factors behind the recent uptick in IRR.

In the wake of COVID-19, GOLD investigates the potential impact of unpredictable events on the industry’s complex distribution network to understand its resilience and vulnerability.

The mRNA COVID-19 vaccine took only a year to develop – beating the previous fastest traditional vaccine development, held by the 1967 mumps vaccine, of four years. How does it differ from traditional vaccine technology?

This infographic explores pharmaceutical trade patterns globally, ranking the top importing and exporting countries, spotlighting the manufacturing hotspots to watch, and investigating the impact of COVID-19 on rates of trade internationally.